Temozolomide Capsule
Product Images NDC 47335-890

8 FDA label images from Sun Pharmaceutical Industries, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Temozolomide (NDC 47335-890). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-temozolomide-structure (Spl Temozolomide Structure)

Spl-temozolomide-structure (Spl Temozolomide Structure)
Chemical structure of Temozolomide, showing a heterocyclic ring with nitrogen atoms, a methyl group, an amide functional group, and a ketone group as part of its molecular configuration.*
FDA Label Image

Spl-temozolomide-figure-1 (Spl Temozolomide Figure 1)

Spl-temozolomide-figure-1 (Spl Temozolomide Figure 1)
A Kaplan-Meier survival curve displaying Overall Survival (%) over Time in Months. Two treatment arms are compared: RT + TMZ (radiotherapy with Temozolomide) shown as a solid line, and RT Only (radiotherapy alone) shown as a dashed line. The graph includes the number of patients at risk at various time points for each group.*
FDA Label Image

Spl-temozolomide-5mg (Temo 5mg)

Spl-temozolomide-5mg (Temo 5mg)
Label for Temozolomide Capsules, USP 5 mg oral capsules by Sun Pharmaceutical Industries, Inc. The label states these are prescription unit-dose capsules in a 5 (1 X 5) count package. It includes a warning that the drug is hazardous, instructions to swallow capsules whole, storage conditions, and distributor information.*
FDA Label Image

Spl-temozolomide-20mg (Temo 20mg)

Spl-temozolomide-20mg (Temo 20mg)
Temozolomide Capsules USP, 20 mg oral capsules by Sun Pharmaceutical Industries, Inc. The label includes a warning indicating it is a hazardous drug, with medication stored in unit-dose blister packaging containing 5 capsules. Storage instructions and manufacturer details are printed, along with a barcode and website for patient information.*
FDA Label Image

Spl-temozolomide-100mg (Temo 100mg)

Spl-temozolomide-100mg (Temo 100mg)
Temozolomide Capsules USP 100 mg oral capsules packaging label, displaying strength prominently. The unit-dose package contains 5 capsules. Label indicates prescription use, hazardous drug warning, and storage instructions. Manufactured by Sun Pharmaceutical Industries, Ltd., India, and distributed by Sun Pharmaceutical Industries, Inc., USA. Includes barcode and patient information URL.*
FDA Label Image

Spl-temozolomide-140mg (Temo 140mg)

Spl-temozolomide-140mg (Temo 140mg)
Label for Temozolomide Capsules USP 140 mg, oral capsules contained in a 5 unit-dose package. Label warns that the drug is hazardous and instructs not to open capsules. Storage instructions specify 25°C with allowable excursions. Manufactured by Sun Pharmaceutical Industries Ltd., India, and distributed by Sun Pharmaceutical Industries, Inc., USA. Contains barcode and dosing caution details.*
FDA Label Image

Spl-temozolomide-180mg (Temo 180mg)

Spl-temozolomide-180mg (Temo 180mg)
Label for Temozolomide Capsules, USP 180 mg, oral capsules by Sun Pharmaceutical Industries, Inc. The package contains 5 unit-dose capsules. The label includes warnings that the drug is hazardous and capsules should be swallowed whole without opening. Storage instructions specify controlled room temperature with permitted excursions. Manufacturer information for Sun Pharmaceutical Industries Ltd., India, and distributor information for Cranbury, NJ are shown.*
FDA Label Image

Spl-temozolomide-250mg (Temo 250mg)

Spl-temozolomide-250mg (Temo 250mg)
Label for Temozolomide Capsules, USP 250 mg by Sun Pharmaceutical Industries, Inc. The label indicates oral administration with 5 unit-dose capsules per package. It includes a warning that the drug is hazardous and should not be opened. Storage instructions specify controlled room temperature. Manufacturer and distributor details are provided from Sun Pharmaceutical Industries in India and New Jersey, respectively.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.